The International Symposium on Pediatric Neuro-Oncology (ISPNO) is the major biennial global meeting of the multi-disciplinary international community of professionals involved in the research, diagnosis, treatment and rehabilitation of infants and children with brain tumors. ISPNO has enjoyed consistent growth since its first meeting in 1986 with over 800 delegates drawn mostly from oncology, neurosurgery and radiation oncology. 16th ISPNO in 2014 will mark the third meeting of ISPNO in the Asian region, as well as the first time it returns to Asia since the 2004 meeting in Japan.
The 16th meeting will take place from 28 June – 02 July 2014 and will be held in conjunction with the 8th St. Jude-VIVA Forum in Pediatric Oncology in Singapore for the first time. Since the first ISPNO meeting in 1986, this biennial scientific conference has witnessed progress that was unimaginable in the 1980s. The pace of discovery and our knowledge of biology, treatment and late effects of pediatric CNS tumors has increased dramatically but many challenges remain, particularly in translating these advances to clinical care in developing nations.
This year is the first time ISPN (International Society of Pediatric Neurosurgery), the ESPN (European Society of Pediatric Neurosurgery), and WFNS (World Federation of Neurosurgical Societies) have collaborated in developing themes and content for multidisciplinary sessions aimed at boosting participation from both regional pediatric neurosurgeons and leaders in the international pediatric neurosurgery community.
It is also the first time the Pediatric Radiation Oncology Society (PROS), has formally joined our International Advisory Board to lead opinions and assist in the design of multidisciplinary sessions during the main ISPNO meeting. We expect this new emphasis to attract even more regional and international pediatric radiation oncology delegates. This meeting is expected to provide a unique opportunity to showcase the latest innovations in radiation oncology and diagnostic imaging as these disciplines are essential elements of therapeutic planning in patients with CNS tumors.
ISPNO is the forum of choice for researchers from North America and Europe to announce pediatric neuro-oncology research results. The meeting encompasses advances in molecular diagnostics and classification, the chemotherapy of tumors of the CNS in Phase III trials, results of trials of investigational new agents from Phase I and II trials and the latest in supportive care.
Professionals involved in the care of children and adolescents are encouraged to benefit from this valuable opportunity to engage with experts, gain insights and establish new collaborations from the enriching plenaries, poster program and more.
Throughout the entire symposium, attendees will engage in dialog regarding new surgical treatments, innovative research and advances in pediatric neuro‐oncology in a dynamic and interactive forum designed to significantly expand the knowledge base of attendees and further enhance overall patient care worldwide.